tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Stock News & Sentiment

Compare
1,153 Followers
Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating
Premium
Ratings
Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating
13d ago
H.C. Wainwright analyst Oren Livnat has reiterated their bullish stance on GRCE stock, giving a Buy rating on February 11. Oren Livnat has given his Buy rating due to a ...Read more
Grace Therapeutics Reports Steady Progress and Financials
Premium
Company Announcements
Grace Therapeutics Reports Steady Progress and Financials
3M ago
ACST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ACST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago

News Score - Last 7 Days

Neutral
GRCE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRCE’s Media Buzz Sentiment?
1 articles about GRCE were published this week. In an average week, 2.25 articles are published.
    What is GRCE’s weekly average amount of articles?
    In an average week, 2.25 articles about GRCE are published.
      What is GRCE’s News Sentiment?
      50% of articles about GRCE were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        JAZZJazz Pharmaceuticals
        CCCCC4 Therapeutics
        MASIMasimo
        CADLCandel Therapeutics
        CORTCorcept Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis